Clinical RoundupFree ACCC report: COVID-19 took a heavy toll on cancer care staff and providers May 28, 2021Vol.47 No.21
Clinical RoundupFree UVA develops tools to advance genomics, cancer research May 28, 2021Vol.47 No.21
Drugs & TargetsFree Rybrevant receives FDA approval as first targeted therapy for subset of NSCLC May 28, 2021Vol.47 No.21
Drugs & TargetsFree Pylarify receives FDA approval as first and only commercially available PSMA PET imaging agent for prostate cancer May 28, 2021Vol.47 No.21
Drugs & TargetsFree Opdivo + Yervoy receives Positive CHMP Opinion for colorectal cancer May 28, 2021Vol.47 No.21
Drugs & TargetsFree Keytruda receives Positive EU CHMP Opinion in combination with chemotherapy as first-line treatment for certain patients with esophageal cancer or HER2- GEJ adenocarcinoma May 28, 2021Vol.47 No.21
Drugs & TargetsFree Venclyxto receives EC approval in combination with a hypomethylating agent for patients with newly diagnosed aml who are ineligible for intensive chemotherapy May 28, 2021Vol.47 No.21
Drugs & TargetsFree Quest Diagnostics, Paige collaborate to advance AI-generated pathology insights to improve cancer diagnosis and care May 28, 2021Vol.47 No.21
Cancer History ProjectFree Donald Pinkel: The cancer pioneer who “introduced the word ‘cure’ to cancer”The Cancer History Project publishes the Donald Pinkel Archive May 21, 2021Vol.47 No.20
FreeIn the Archives The sixth vital sign, radiation oncology, and cancer causation: Jimmie Holland, Gerald Hanks, and Alfred Knudson May 21, 2021Vol.47 No.20
